[Ⅲ. Clinical Trials of Trastuzumab Deruxtecan for HER2-Low Advanced Breast Cancer]

Gan To Kagaku Ryoho. 2023 Dec;50(12):1278-1281.

[Article in Japanese]

Authors

Rika Kizawa¹, Toshimi Takano

Affiliation

¹ Dept. of Breast Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research.

PMID: 38247065

No abstract available

MeSH terms

Breast Neoplasms* / drug therapy
Breast Neoplasms* / genetics
Camptothecin
Female
Genes, erbB-2
Humans
Immunoconjugates*
Trastuzumab / therapeutic use

Substances

Camptothecin
Immunoconjugates
Trastuzumab
trastuzumab deruxtecan